Read Online Pharmacy Reviews for Secured Benefits

An online pharmacy may be considered as one of the most useful shops in the internet. Anybody needing medicine, with or without prescription, can simply order online and have their purchased item within a few days. The industry of online pharmacies has been growing immensely; however, they come and go very fast. People should know its benefits and the one thing they need to do first before giving their credit card details is to close the deal.The advantages of buying medications in a web-based pharmacy are listed below.2C’s: Convenient and CheapThe internet is almost synonymous with the word “convenient” today. It allows people to do many things, even buy medicines. Purchasing medicines online is most suitable to people who have a busy schedule, most especially professional working men and women. Sometimes, these people simply do not have enough time to do all the things they need to do. When they get sick and have no time to visit the doctor, they go to an online pharmacy for no prescription drugs.Apart from being convenient and available 24/7, medications sold online are cheaper compared to the ones sold in traditional pharmacies. That is because there are no added overhead charges on medicines bought from an online pharmacy. There are even other pharmacies who offer discounts for pharmacy members and exclusive access to exclusive medicines.2P’s: Private and problem-freeWhether you are buying medication for an embarrassing illness or allergy, you can buy them without personally asking for it through a pharmacy online. Buying medications won’t be embarrassing anymore because you only need to fill out a form online for your order. After you have paid for it, it will be delivered to your given address.In a regular pharmacy, you need to have a prescription from your doctor to buy a specific type of drugs. In an online pharmacy, no prescription orders are accepted. It gives you fewer headaches and fewer problems. Buying online is easier and problem-free.Those are the four basic benefits you can get from buying medicines online. Despite those, you should still exercise caution when looking for pharmacies online. No matter how much they advertise on the internet, you should not purchase medicines without reading customer reviews first.Find a website that provides various customer feedbacks about different pharmacies found online.Before purchasing or ordering any product you find in a web-based pharmacy, make sure you have read about them first. It is easy to fall prey to criminals online when you are not prepared for them. Once you found a pharmacy wherein you would like to purchase a specific item, look them up online and do a background check. You can probably look for websites that allow customers to comment on web-based pharmacies. Positive and negative comments are accepted to let other people know the kind of service a web-based pharmacy can offer.There are so many reasons purchasing medicines from an online pharmacy is better than a land-based pharmacy. Despite those benefits, you have to be really careful first before buying one. Read online reviews about pharmacies to know which companies are reliable and safe, and provide quality products and customer service.

I Will Be Strongly Disliked by Nutrition Cults After This Article is Published

“No soup for you!” This became the cry of the “Soup Nazi” in one episode of the popular series Seinfeld when it was on. The plot is that one of the crew eats soup that is to die for, and the others won’t believe soup can be so good until they try it. When they go to the shop that sells the soup, there is a long line of people wanting this soup. Each person methodically and silently moves through the line, reaching and taking without talking to the chef. One of Jerry’s friends (or maybe it was him? anyway…) commits a horrible faux-pas and talks to the chef and doesn’t do something the way he should and ends up banned from the soup line, with the grouchy chef yelling this famous line after him as he leaves.The Soup Nazi came to mind the other week when I was musing over the latest nutrition fad to hit the market. Because I market liquid whole food nutrition as supplements to healthcare practitioners and those involved in the nutrition field, I hear a lot of people telling clients some pretty strange things. It’s not wrong to try something that someone you trust recommends. However, when someone issues mandates and absolutes about diets without the science to back it up, I start getting perturbed. So, I’ve coined a term for the people who are so far at the end of the nutrition spectrum that they have fallen off: Nutrition Nazis.A Nutrition Nazi is someone who requires another person to eat a plate of peas for lunch every single day. A Nutrition Nazi is a person who scares other people into eating certain foods with such authority that all types of (insert a certain food category) are eliminated from the diet. A Nutrition Nazi is a person who will not accept any other suggestions offered to a client if it is not made by them. A Nutrition Nazi will not accept clients if they do (insert something here that seems random) or don’t do (insert something else that seems random).Actually, you have probably seen Nutrition Nazis on TV (maybe even on Oprah!). You may have met one, or even followed one for awhile. They are people who make other people feel bad if they aren’t like them. They use nutrition as a reward and as a punishment. They look great, and they are healthy. But they make one mistake in their training that is a deal-breaker:They tell people to do things that aren’t enjoyable!I do believe in many, many things about nutrition that science, experience, and history back up as wise practices. These things come from all different sources. Anyone who converts his/her nutrition habits to even 20% of them would at least experience a greater sense of well-being and would be investing in their future good health. And I know better than to tell people to do these things.Good nutrition cannot be presented to clients as a god to please. I have yet to meet one person who craves failure, and to hold good nutrition up as something high to aspire to will create failure. So much in our culture that doesn’t relate to the stuff on our plates is twisted up in foods that I refuse to address clients in such black and white terms. If you happen to meet a Nutrition Nazi, I strongly suggest asking them up front what they won’t let you eat. Follow that with a question of what is the one food you should eat everyday. If they answer any food after question one, don’t sign any papers. If they tell you something odd, expensive, or yucky, make a one-eighty and tell them you’ll think about it. I hope you’ll think about how odd or expensive or yucky that food would be to eat everyday, and then think about finding some other sources (yes, plural) to help you grow in this area.

Nutritional Yeast vs. Vitamin Supplements

Nutritional yeast is deactivated yeast–often, Saccharomyces cerevisiae–that is yellow in color and has a nutty and cheesy flavor. It is a reliable food source for vitamins, especially B-complex vitamins such as folic acid. It is also an excellent source of protein (52%) and contains essential amino acids–making it a very popular choice for vegans. Some products are fortified with vitamin B12, which is produced separately from bacteria. Because of its rich nutrient content, nutritional yeast is a very good choice to include in a daily diet, instead of taking synthetically formulated vitamin supplements. Some of the benefits of nutritional yeast vs. vitamin supplements are discussed here.1. Flavor When it comes to the flavor of nutritional yeast vs. vitamin supplements, nutritional yeast is the winner. Nutritional yeast has a nutty, cheesy, and creamy flavor that makes it an excellent cheese substitute–in fact, it is often used by vegans as a substitute to parmesan cheese. Nutritional yeast comes in the form of flakes or powder, and can thus be sprinkled to almost anything–from popcorn, bread, and vegetables, to pizzas, pastas, and casseroles.Meanwhile, how many vitamin supplements can be used to flavor or enhance food? This alone gives you enough reason to go for nutritional yeast (vs. vitamin supplements). Because of its unique flavor and the many versatile ways it can be added into food, nutritional yeast (vs. vitamin supplements) are easier to ingest and administer to kids and adults alike. Furthermore, nutritional yeast is low in fat and salt, making it perfect for those who are watching their weight.2. Natural vs. synthetic Nutritional yeast vs. vitamin supplements is different in how they store nutrients. Nutritional yeast is naturally grown–providing vitamins and nutrients at their natural state. It is not processed, and therefore, is a whole, organic, food vitamin. Inorganic vitamin supplements on the other hand–those that are not obtained or extracted from whole foods–are usually synthesized in high concentrates. Some say that vitamins and mineral elements are so complex and dependent upon each other, that when they are separated, they can no longer provide the same nutritional effect on the body.Thus, high concentrations of synthetic vitamins may not be beneficial. On the other hand, nutritional yeast provides vitamins in their complete form–including all their parts and cofactors–because they are derived from whole foods.3. When vitamin supplements are better Of course, nutritional yeast is not always better. Some ingredients and contents of vitamin supplements are not found in nutritional yeast and may be needed to counter deficiencies of meet Recommended Daily Allowances. When weighing nutritional yeast vs. vitamin supplements, it is still advisable to consult a physician to find out what’s best for you.IMPORTANT: Keep in mind that the sale and distribution of nutritional yeast and vitamin supplements are unregulated by the Food and Drug Administration Board. As much as you can, buy only products from a manufacturer that strictly follows and adheres to the GMP standards. This assures you that the product contains the right amount of ingredients and dosage indicated, and that it is free from known contaminants.

Top 2 Tech Marketer Challenges (and Solutions)

If you’re a tech marketer, you’re already aware of the particularly difficult challenges you face. Sure, all marketers have difficult challenges, but the ever-changing tech world introduces new complexity to the marketing mix. After all, the technology industry is growing and changing so fast that no one can possibly keep up. No one, of course, except for the tech marketer, who is not only charged with keeping up, but also staying one step ahead of the marketplace.LinkedIn recently published an article discussing some of the top challenges experienced by tech marketers today. Here are two of those challenges, along with actionable information you can use to start overcoming them now.Challenge #1: Identifying the decision maker?All marketers know how important it is to identify and understand the decision maker. Without this knowledge, it’s difficult to build a successful marketing strategy to win them over.The difficulty with tech marketing, though, is that the decision maker isn’t a single person. Instead, it’s now a cross-functional group comprised of IT, Marketing, Sales, Operations, Finance and more.This complexity makes it all the more important to fully understand the needs, challenges and motivations of each group member and appeal to them directly.A recent LinkedIn study of groups that hold decision-making power over IT and technology purchases discovered that nurturing prospects with informative content is a vital part of the sales process. Why? Because members of these groups are typically not ready to talk to a sales rep until they have consumed at least five pieces of “relevant, unbranded, non-sales focused content”.Additionally, LinkedIn’s post highlights the importance of producing content for every role on this cross-functional buying committee… at every stage in the buying process. Because, as the post explains, the tech decision maker is a group, not an individual, marketers have a responsibility to reach out to and engage with every one of them. You never know who will make that first contact, who will lead the buying committee, or who will have the most influence over the other members.That’s why it’s critical to have a strategy for how to reach, engage and ultimately convert every member of the group at each stage in the buying process. It sounds like a lot of work, yes, but tech marketers have the opportunity to influence every member of the buying committee and begin to win them over through always-on education. What’s “always-on”? It’s content that provides valuable, educational information at every stage of the buying process – anytime the users may want it. When you consider that, according to the Content Marketing Institute, 63% of tech buyers are more likely to consider vendors that take an always-on approach, it’s worth the effort.Challenge #2: Creating Engaging ContentAccording to the Content Marketing Institute, 93% of tech marketers use content marketing. However, they also say that “creating engaging content” has been a top challenge for the last five years. What does this tells us? While tech marketers see value in content marketing, they also have limited time and resources, which keeps them from creating content that is as successful as it really could be.So how do you compete in the saturated tech marketplace? According to LinkedIn’s post, build a reliable toolbox. If you think about it, there are more content marketing tools and resources available today than ever before – many of which are free or very reasonably priced. Marketers have more options available now than ever before to design, create, write, build and develop on their own – free of any outside support. Just think about what has done for marketers!If you’re a tech marketer, you understand the pressure to stay ahead of the ridiculously fast-paced world of innovation. It’s our job to not only reach out to, but also engage some of the brightest, most forward-thinking minds in the industry. Thankfully, there are tools and resources to help make it possible.

S&P 500 Rallies As U.S. Dollar Pulls Back Towards Weekly Lows

Key Insights
The strong pullback in the U.S. dollar provided significant support to stocks.
Treasury yields have pulled back after touching new highs, which served as an additional positive catalyst for S&P 500.
A move above 3730 will push S&P 500 towards the resistance level at 3760.
Advertisement

Pfizer Rallies After Announcing A Huge Price Hike For Its COVID-19 Vaccines
S&P 500 is currently trying to settle above 3730 as traders’ appetite for risk is growing. The U.S. dollar has recently gained strong downside momentum as the BoJ intervened to stop the rally in USD/JPY. Weaker U.S. dollar is bullish for stocks as it increases profits of multinational companies and makes U.S. equities cheaper for foreign investors.

The leading oil services company Schlumberger is up by 9% after beating analyst estimates on both earnings and revenue. Schlumberger’s peers Baker Hughes and Halliburton have also enjoyed strong support today.

Vaccine makers Pfizer and Moderna gained strong upside momentum after Pfizer announced that it will raise the price of its coronavirus vaccine to $110 – $130 per shot.

Biggest losers today include Verizon and Twitter. Verizon is down by 5% despite beating analyst estimates on both earnings and revenue. Subscriber numbers missed estimates, and traders pushed the stock to multi-year lows.

Twitter stock moved towards the $50 level as the U.S. may conduct a security review of Musk’s purchase of the company.

From a big picture point of view, today’s rebound is broad, and most market segments are moving higher. Treasury yields have started to move lower after testing new highs, providing additional support to S&P 500. It looks that some traders are ready to bet that Fed will be less hawkish than previously expected.

S&P 500 Tests Resistance At 3730

S&P 500 has recently managed to get above the 20 EMA and is trying to settle above the resistance at 3730. RSI is in the moderate territory, and there is plenty of room to gain additional upside momentum in case the right catalysts emerge.

If S&P 500 manages to settle above 3730, it will head towards the next resistance level at 3760. A successful test of this level will push S&P 500 towards the next resistance at October highs at 3805. The 50 EMA is located in the nearby, so S&P 500 will likely face strong resistance above the 3800 level.

On the support side, the previous resistance at 3700 will likely serve as the first support level for S&P 500. In case S&P 500 declines below this level, it will move towards the next support level at 3675. A move below 3675 will push S&P 500 towards the support at 3640.

SPDN: An Inexpensive Way To Profit When The S&P 500 Falls

Summary
SPDN is not the largest or oldest way to short the S&P 500, but it’s a solid choice.
This ETF uses a variety of financial instruments to target a return opposite that of the S&P 500 Index.
SPDN’s 0.49% Expense Ratio is nearly half that of the larger, longer-tenured -1x Inverse S&P 500 ETF.
Details aside, the potential continuation of the equity bear market makes single-inverse ETFs an investment segment investor should be familiar with.
We rate SPDN a Strong Buy because we believe the risks of a continued bear market greatly outweigh the possibility of a quick return to a bull market.
Put a gear stick into R position, (Reverse).
Birdlkportfolio

By Rob Isbitts

Summary
The S&P 500 is in a bear market, and we don’t see a quick-fix. Many investors assume the only way to navigate a potentially long-term bear market is to hide in cash, day-trade or “just hang in there” while the bear takes their retirement nest egg.

The Direxion Daily S&P 500® Bear 1X ETF (NYSEARCA:SPDN) is one of a class of single-inverse ETFs that allow investors to profit from down moves in the stock market.

SPDN is an unleveraged, liquid, low-cost way to either try to hedge an equity portfolio, profit from a decline in the S&P 500, or both. We rate it a Strong Buy, given our concern about the intermediate-term outlook for the global equity market.

Strategy
SPDN keeps it simple. If the S&P 500 goes up by X%, it should go down by X%. The opposite is also expected.

Proprietary ETF Grades
Offense/Defense: Defense

Segment: Inverse Equity

Sub-Segment: Inverse S&P 500

Correlation (vs. S&P 500): Very High (inverse)

Expected Volatility (vs. S&P 500): Similar (but opposite)

Holding Analysis
SPDN does not rely on shorting individual stocks in the S&P 500. Instead, the managers typically use a combination of futures, swaps and other derivative instruments to create a portfolio that consistently aims to deliver the opposite of what the S&P 500 does.

Strengths
SPDN is a fairly “no-frills” way to do what many investors probably wished they could do during the first 9 months of 2022 and in past bear markets: find something that goes up when the “market” goes down. After all, bonds are not the answer they used to be, commodities like gold have, shall we say, lost their luster. And moving to cash creates the issue of making two correct timing decisions, when to get in and when to get out. SPDN and its single-inverse ETF brethren offer a liquid tool to use in a variety of ways, depending on what a particular investor wants to achieve.

Weaknesses
The weakness of any inverse ETF is that it does the opposite of what the market does, when the market goes up. So, even in bear markets when the broader market trend is down, sharp bear market rallies (or any rallies for that matter) in the S&P 500 will cause SPDN to drop as much as the market goes up.

Opportunities
While inverse ETFs have a reputation in some circles as nothing more than day-trading vehicles, our own experience with them is, pardon the pun, exactly the opposite! We encourage investors to try to better-understand single inverse ETFs like SPDN. While traders tend to gravitate to leveraged inverse ETFs (which actually are day-trading tools), we believe that in an extended bear market, SPDN and its ilk could be a game-saver for many portfolios.

Threats
SPDN and most other single inverse ETFs are vulnerable to a sustained rise in the price of the index it aims to deliver the inverse of. But that threat of loss in a rising market means that when an investor considers SPDN, they should also have a game plan for how and when they will deploy this unique portfolio weapon.

Proprietary Technical Ratings
Short-Term Rating (next 3 months): Strong Buy

Long-Term Rating (next 12 months): Buy

Conclusions
ETF Quality Opinion
SPDN does what it aims to do, and has done so for over 6 years now. For a while, it was largely-ignored, given the existence of a similar ETF that has been around much longer. But the more tenured SPDN has become, the more attractive it looks as an alternative.

ETF Investment Opinion

SPDN is rated Strong Buy because the S&P 500 continues to look as vulnerable to further decline. And, while the market bottomed in mid-June, rallied, then waffled since that time, our proprietary macro market indicators all point to much greater risk of a major decline from this level than a fast return to bull market glory. Thus, SPDN is at best a way to exploit and attack the bear, and at worst a hedge on an otherwise equity-laden portfolio.

S&P 500 Biotech Giant Vertex Leads 5 Stocks Showing Strength

Your stocks to watch for the week ahead are Cheniere Energy (LNG), S&P 500 biotech giant Vertex Pharmaceuticals (VRTX), Cardinal Health (CAH), Steel Dynamics (STLD) and Genuine Parts (GPC).

X
While the market remains in correction, with analysts and investors wary of an economic downturn, these five stocks are worth adding to watchlists. S&P 500 medical giants Vertex and Cardinal Health have been holding up, as health-care related plays tend to do well in down markets.

Steel Dynamics and Genuine Parts are both coming off strong earnings as both the steel and auto parts industries report optimistic outlooks. Meanwhile, Cheniere Energy saw sales boom in the second quarter as demand in Europe for natural gas continues to grow.

Major indexes have been making rally attempts with the Dow Jones and S&P 500 testing weekly support on Friday. With market uncertainty, investors should be ready for follow-through day breakouts and keep an eye on these stocks.

Cheniere Energy, Cardinal Health and VRTX stock are all on IBD Leaderboard.

Cheniere Energy Stock
LNG shares rose 1.1% to 175.79 during Friday’s market trading. On the week, the stock advanced 3.1%, not from highs, bouncing from its 21-day and 10-week lines earlier in the week.

Cheniere Energy has been consolidating since mid-September, but needs another week to forge a proper base, with a potential 182.72 buy point formed on Aug. 10.

Houston-based Cheniere Energy was IBD Stock Of The Day on Thursday, as the largest U.S. producer of liquefied natural gas eyes strong demand in Europe.

Even though natural gas prices are plunging in the U.S. and Europe, investors still see strong LNG demand for Cheniere and others.

The U.K. government confirmed last week that it is in talks for an LNG purchase agreement with a number of companies, including Cheniere.

In the first half of 2021, less than 40% of Cheniere’s cargoes of LNG landed in Europe. That jumped to more than 70% through this year’s second quarter, even as the company ramped up new export capacity. The urgency of Europe’s natural gas shortage only intensified last month. That is when an explosion disabled the Nord Stream 1 pipeline from Russia that had once supplied 40% of the European Union’s natural gas.

In Q2, sales increased 165% to $8 billion and LNG earned $2.90 per share, up from a net loss of $1.30 per share in Q2 2021. The company will report Q3 earnings Nov. 3, with investors seeing booming profits for the next few quarters.

Cheniere Energy has a Composite Rating of 84. It has a 98 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share price movement with a 1 to 99 score. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 41.

Vertex Stock
VRTX stock jumped 3.4% to 300 on Friday, rebounding from a test of its 50-day moving average. Shares climbed 2.2% for the week. Vertex stock has formed a tight flat base with an official buy point of 306.05, according to MarketSmith analysis.

The stock has remained consistent over recent weeks, while the relative strength line has trended higher. The RS line tracks a stock’s performance vs. the S&P 500 index.

Vertex Q3 earnings are on due Oct. 27. Analysts see EPS edging up 1% to $3.61 per share with sales increasing 16% to $2.2 billion, according to FactSet.

The Boston-based global biotech company dominates the cystic fibrosis treatment market. Vertex also has other products in late-stage clinical development that target sickle cell disease, Type 1 diabetes and certain genetically caused kidney diseases. That includes a gene-editing partnership with Crispr Therapeutics (CRSP).

In early August, Vertex reported better-than-expected second-quarter results and raised full-year sales targets.

S&P 500 stock Vertex ranks second in the Medical-Biomed/Biotech industry group. VRTX has a 99 Composite Rating. Its Relative Strength Rating is 94 and its EPS Rating is 99.

CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?

Cardinal Health Stock
CAH stock advanced 3.2% to 73.03 Friday, clearing a 71.22 buy point from a shallow cup-with-handle base and hitting a record high. But volume was light on the breakout. CAH stock leapt 7.3% for the week.

Cardinal Health stock’s relative strength line has also been trending up for months.

The cup-with-handle base is part of a base-on-base pattern, forming just above a cup base cleared on Aug. 11.

Cardinal Health, based in Dublin, Ohio, offers a wide assortment of health care services and medical supplies to hospitals, labs, pharmacies and long-term care facilities. The company reports that it serves around 90% of hospitals and 60,000 pharmacies in the U.S.

S&P 500 stock Cardinal Health will report Q1 2023 earnings on Nov. 4. Analysts forecast earnings falling 26% to 96 cents per share. Sales are expected to increase 10% to $48.3 billion, according to FactSet.

Cardinal Health stock ranks first in the Medical-Wholesale Drug/Supplies industry group, ahead of McKesson (MCK), which is also showing positive action. CAH stock has a 94 Composite Rating out of 99. It has a 97 Relative Strength Rating and an EPS rating of 73.

Steel Dynamics Stock
STLD shares shot up 8.5% to 92.92 on Friday and soared 19% on the week, coming off a Steel Dynamics earnings beat Wednesday night.

Shares blasted above an 88.72 consolidation buy point Friday after clearing a trendline Thursday. STLD stock is 17% above its 50-day line, definitely extended from that key average.

Steel Dynamics’ latest consolidation could be seen as part of a larger base going back six months.

Steel Dynamics topped Q3 earnings views with EPS rising 10% to $5.46 while revenue grew 11% to $5.65 billion. The steel producer’s outlook is optimistic despite weaker flat rolled steel pricing. STLD reports its order activity and backlogs remain solid.

The Fort Wayne, Indiana-based company is among the largest producers of carbon steel products in the U.S. It engages in metal recycling operations along with steel fabrication and produces myriad steel products.

How Millett Grew Steel Dynamics From A Three Employee Business

STLD stock ranks first in the Steel-Producers industry group. STLD stock has a 96 Composite Rating out of 99. It has a 90 Relative Strength Rating, an exclusive IBD Stock Checkup gauge for share-price movement that tops at 99. The rating shows how a stock’s performance over the last 52 weeks holds up against all the other stocks in IBD’s database. The EPS rating is 98.

Genuine Parts Stock
GPC stock gained 2.8% to 162.35 Friday after the company topped earnings views with its Q3 results on Thursday. For the week GPC advanced 5.1% as the stock held its 50-day line and is in a flat base.

GPC has an official 165.09 flat-base buy point after a three-week rally, according to MarketSmith analysis.

The relative strength line for Genuine Parts stock has rallied sharply to highs over the past several months.

On Thursday, the Atlanta-based auto parts company raised its full-year guidance on growth across its automotive and industrial sales.

Genuine Parts earnings per share advanced 19% to $2.23 and revenue grew 18% to $5.675 billion in Q3. GPC’s full-year guidance is now calling for EPS of $8.05-$8.15, up from $7.80-$7.95. The company now forecasts revenue growth of 15%-16%, up from the earlier 12%-14%.

During the Covid pandemic, supply chain constraints caused a major upheaval in the auto industry, sending prices for new and used cars to record levels. This has made consumers more likely to hang on to their existing vehicles for longer, driving mileage higher and boosting demand for auto replacement parts.

Fellow auto stocks O’Reilly Auto Parts (ORLY) and AutoZone (AZO) have also rallied near buy points amid the struggling market. O’Reilly reports on Oct. 26.

IBD ranks Genuine Parts first in the Retail/Wholesale-Auto Parts industry group. GPC stock has a 96 Composite Rating. Its Relative Strength Rating is 94 and it has an EPS Rating of 89.

Shoe Repairs And Several Other Things When I Was 7

Shoe Repairs And Several Other Things When I Was 7
My Dad repaired most of our shoes believe it or not, I can hardly believe it myself now. With 7 pairs of shoes always needing repairs I think he was quite clever to learn how to “Keep us in shoe Leather” to coin a phrase!

He bought several different sizes of cast iron cobbler’s “lasts”. Last, the old English “Laest” meaning footprint. Lasts were holding devices shaped like a human foot. I have no idea where he would have bought the shoe leather. Only that it was a beautiful creamy, shiny colour and the smell was lovely.

But I do remember our shoes turned upside down on and fitted into these lasts, my Dad cutting the leather around the shape of the shoe, and then hammering nails, into the leather shape. Sometimes we’d feel one or 2 of those nails poking through the insides of our shoes, but our dad always fixed it.

Hiking and Swimming Galas
Dad was a very outdoorsy type, unlike my mother, who was probably too busy indoors. She also enjoyed the peace and quiet when he took us off for the day!

Anyway, he often took us hiking in the mountains where we’d have a picnic of sandwiches and flasks of tea. And more often than not we went by steam train.

We loved poking our heads out of the window until our eyes hurt like mad from a blast of soot blowing back from the engine. But sore, bloodshot eyes never dampened our enthusiasm.

Dad was an avid swimmer and water polo player, and he used to take us to swimming galas, as they were called back then. He often took part in these galas. And again we always travelled by steam train.

Rowing Over To Ireland’s Eye
That’s what we did back then, we had to go by rowboat, the only way to get to Ireland’s eye, which is 15 minutes from mainland Howth. From there we could see Malahide, Lambay Island and Howth Head of course. These days you can take a Round Trip Cruise on a small cruise ship!

But we thoroughly enjoyed rowing and once there we couldn’t wait to climb the rocks, and have a swim. We picnicked and watched the friendly seals doing their thing and showing off.

Not to mention all kinds of birdlife including the Puffin.The Martello Tower was also interesting but a bit dangerous to attempt entering. I’m getting lost in the past as I write, and have to drag myself back to the present.

Fun Outings with The camera Club
Dad was also a very keen amateur photographer, and was a member of a camera Club. There were many Sunday photography outings and along with us came other kids of the members of the club.

And we always had great fun while the adults busied themselves taking photos of everything and anything, it seemed to us. Dad was so serious about his photography that he set up a dark room where he developed and printed his photographs.

All black and white at the time. He and his camera club entered many of their favourites in exhibitions throughout Europe. I’m quite proud to say that many cups and medals were won by Dad. They have been shared amongst all his grandchildren which I find quite special.

He liked taking portraits of us kids too, mostly when we were in a state of untidiness, usually during play. Dad always preferred the natural look of messy hair and clothes in the photos of his children.

US Markets in green on Friday; Dow 30 up over 345 points, Nasdaq Composite, S&P 500 up nearly 1%

US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 1.14%. While S&P 500 was trading at 3,701.66, up by 0.98% and Nasdaq Composite 10,690.60 was also up by 0.71 per cent

Twitter Facebook Linkedin
US Markets in green on Friday; Dow 30 up over 345 points, Nasdaq Composite, S&P 500 up nearly 1%
Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. Source: Reuters
US Markets were trading in the green on Friday with Dow 30 trading at 30,678.80, up by 345.25 points or1.14 per cent. While S&P 500 was trading at 3,701.66, up by 35.88 points or 0.98 per cent and Nasdaq Composite 10,690.60 was also up 75.75 points or 0.71 per cent. A Reuters report said that today’s strength was on the back of a report which said the Federal Reserve will likely debate on signaling plans for a smaller interest rate hike in December, reversing declines set off by social media firms after Snap Inc’s ad warning.

Source: Comex

Nasdaq Top Gainers and Losers

Source: Nasdaq

Earlier today, Indian stock markets ended the week on a winning note. It was the sixth straight gains for equity markets. The BSE Sensex ended at 59,307.15, up by 104.25 points or 0.18 per cent from the Thursday closing level. Meanwhile, the Nifty50 index closed at 17,590.00, higher by 26.05 points or 0.15 per cent. In the 30-share Sensex, 13 stocks gained while the remaining 17 ended on the losing side. In the 50-stock Nifty50, 21 stocks advanced while 29 declined.

Alternative Financing Vs. Venture Capital: Which Option Is Best for Boosting Working Capital?

There are several potential financing options available to cash-strapped businesses that need a healthy dose of working capital. A bank loan or line of credit is often the first option that owners think of – and for businesses that qualify, this may be the best option.

In today’s uncertain business, economic and regulatory environment, qualifying for a bank loan can be difficult – especially for start-up companies and those that have experienced any type of financial difficulty. Sometimes, owners of businesses that don’t qualify for a bank loan decide that seeking venture capital or bringing on equity investors are other viable options.

But are they really? While there are some potential benefits to bringing venture capital and so-called “angel” investors into your business, there are drawbacks as well. Unfortunately, owners sometimes don’t think about these drawbacks until the ink has dried on a contract with a venture capitalist or angel investor – and it’s too late to back out of the deal.

Different Types of Financing

One problem with bringing in equity investors to help provide a working capital boost is that working capital and equity are really two different types of financing.

Working capital – or the money that is used to pay business expenses incurred during the time lag until cash from sales (or accounts receivable) is collected – is short-term in nature, so it should be financed via a short-term financing tool. Equity, however, should generally be used to finance rapid growth, business expansion, acquisitions or the purchase of long-term assets, which are defined as assets that are repaid over more than one 12-month business cycle.

But the biggest drawback to bringing equity investors into your business is a potential loss of control. When you sell equity (or shares) in your business to venture capitalists or angels, you are giving up a percentage of ownership in your business, and you may be doing so at an inopportune time. With this dilution of ownership most often comes a loss of control over some or all of the most important business decisions that must be made.

Sometimes, owners are enticed to sell equity by the fact that there is little (if any) out-of-pocket expense. Unlike debt financing, you don’t usually pay interest with equity financing. The equity investor gains its return via the ownership stake gained in your business. But the long-term “cost” of selling equity is always much higher than the short-term cost of debt, in terms of both actual cash cost as well as soft costs like the loss of control and stewardship of your company and the potential future value of the ownership shares that are sold.

Alternative Financing Solutions

But what if your business needs working capital and you don’t qualify for a bank loan or line of credit? Alternative financing solutions are often appropriate for injecting working capital into businesses in this situation. Three of the most common types of alternative financing used by such businesses are:

1. Full-Service Factoring – Businesses sell outstanding accounts receivable on an ongoing basis to a commercial finance (or factoring) company at a discount. The factoring company then manages the receivable until it is paid. Factoring is a well-established and accepted method of temporary alternative finance that is especially well-suited for rapidly growing companies and those with customer concentrations.

2. Accounts Receivable (A/R) Financing – A/R financing is an ideal solution for companies that are not yet bankable but have a stable financial condition and a more diverse customer base. Here, the business provides details on all accounts receivable and pledges those assets as collateral. The proceeds of those receivables are sent to a lockbox while the finance company calculates a borrowing base to determine the amount the company can borrow. When the borrower needs money, it makes an advance request and the finance company advances money using a percentage of the accounts receivable.

3. Asset-Based Lending (ABL) – This is a credit facility secured by all of a company’s assets, which may include A/R, equipment and inventory. Unlike with factoring, the business continues to manage and collect its own receivables and submits collateral reports on an ongoing basis to the finance company, which will review and periodically audit the reports.

In addition to providing working capital and enabling owners to maintain business control, alternative financing may provide other benefits as well:

It’s easy to determine the exact cost of financing and obtain an increase.
Professional collateral management can be included depending on the facility type and the lender.
Real-time, online interactive reporting is often available.
It may provide the business with access to more capital.
It’s flexible – financing ebbs and flows with the business’ needs.
It’s important to note that there are some circumstances in which equity is a viable and attractive financing solution. This is especially true in cases of business expansion and acquisition and new product launches – these are capital needs that are not generally well suited to debt financing. However, equity is not usually the appropriate financing solution to solve a working capital problem or help plug a cash-flow gap.

A Precious Commodity

Remember that business equity is a precious commodity that should only be considered under the right circumstances and at the right time. When equity financing is sought, ideally this should be done at a time when the company has good growth prospects and a significant cash need for this growth. Ideally, majority ownership (and thus, absolute control) should remain with the company founder(s).

Alternative financing solutions like factoring, A/R financing and ABL can provide the working capital boost many cash-strapped businesses that don’t qualify for bank financing need – without diluting ownership and possibly giving up business control at an inopportune time for the owner. If and when these companies become bankable later, it’s often an easy transition to a traditional bank line of credit. Your banker may be able to refer you to a commercial finance company that can offer the right type of alternative financing solution for your particular situation.

Taking the time to understand all the different financing options available to your business, and the pros and cons of each, is the best way to make sure you choose the best option for your business. The use of alternative financing can help your company grow without diluting your ownership. After all, it’s your business – shouldn’t you keep as much of it as possible?